State Key Laboratory of Drug Research (SKLDR), which was approved by Chinese Academy of Sciences under the unremitting efforts of reorganizing the state key laboratory system, is recruiting a Deputy Director. The candidate is expected to help SKLDR to continuously improve the academic influence and the ability to transform new drug achievements into real productivity.
Trending - Altmetric
Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies
Formyl peptide receptor 2 as a potential therapeutic target for inflammatory bowel disease
Pharmacological effects of saw palmetto extract in the lower urinary tract
Cannabis, cannabinoid receptors, and endocannabinoid system: yesterday, today, and tomorrow